NPS-2143通过通过介导AKT-mTOR途径抑制自来抑制结质瘤进展
Jia-Li Nie1,2, Qi Li1,2, Hai-Tang Yin1,2
1Department of Pharmacy, Affiliated Hospital of Guizhou Medical University, Guiyang, P.R. China.
Journal of cellular and molecular medicine
|March 21, 2024
概括
作为感应受体对手的NPS-2143,通过抑制细胞增殖,诱导细胞亡和阻断自,有效地抑制质瘤的进展. 这种化合物显示出作为抗质瘤治疗剂的前景.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 质瘤是最常见的中枢神经系统瘤.
- 识别新型治疗化合物和理解它们的机制对于有效的质瘤治疗至关重要.
研究的目的:
- 为了发现一种强大的抗质瘤化合物.
- 阐明其抗瘤作用背后的分子机制.
主要方法:
- 使用CCK-8试验对50种化合物的细胞毒性查用于质瘤细胞.
- 研究了细胞周期,细胞亡,迁移,入侵和自.
- 使用生物信息分析和裸体小鼠异种移植模型.
主要成果:
- 作为感受受体 (CASR) 抗体的NPS-2143,对瘤细胞表现出强烈的细胞毒性.
- NPS-2143抑制了增殖,诱导了G1细胞周期停止和细胞亡,并减少了迁移/入侵.
- NPS-2143通过AKT-mTOR途径抑制了自,并在体内证明了瘤抑制.
结论:
- 通过抑制自,NPS-2143有效地抑制了质瘤的进展.
- CASR表达水平与质瘤患者的预后相关,这表明CASR是潜在的治疗点.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


